Citation Impact
Citing Papers
The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
2012
Complement Factor H Polymorphism in Age-Related Macular Degeneration
2005 StandoutScience
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease
2014
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH
2011
Mechanisms, regulation and functions of the unfolded protein response
2020 Standout
Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis
2011
Functions of DNA methylation: islands, start sites, gene bodies and beyond
2012 Standout
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
2012
Hepatocellular carcinoma
2016 Standout
Isolation, identification, and biological evaluation of HIF-1-modulating compounds from Brazilian green propolis
2011 StandoutNobel
Non-alcoholic fatty liver disease: A sign of systemic disease
2017
Mechanisms of hepatic stellate cell activation
2017 Standout
Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activation
2020
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
The molecular basis of human retinal and vitreoretinal diseases
2010 Standout
TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment
2017
Hypoxia and Hypoxia Inducible Factors: Diverse Roles in Liver Diseases
2011
Global Mapping of DNA Methylation in Mouse Promoters Reveals Epigenetic Reprogramming of Pluripotency Genes
2008
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Macrophages: Master Regulators of Inflammation and Fibrosis
2010 Standout
Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications
2010
Functional Classification and Experimental Dissection of Long Noncoding RNAs
2018 Standout
Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa
1998
MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression
2016
Genetic factors of age-related macular degeneration
2004
Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-1 in the Retinal Pigment Epithelium and Interphotoreceptor Matrix: Vectorial Secretion and Regulation
1997
That impish TIMP: the tissue inhibitor of metalloproteinases-3
2001
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Hepatic tumor–stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge
2009
An “imaging-biopsy” strategy for colorectal tumor reconfirmation by multipurpose paramagnetic quantum dots
2015
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
2011
Targeting inflammation in diabetes: Newer therapeutic options
2014
DNA methylation: roles in mammalian development
2013 Standout
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
The tumor microenvironment
2020 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby’s fundus dystrophy with unusual clinical features
1998
Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis
2018
Long non-coding RNAs: new players in cell differentiation and development
2013 Standout
Vascular endothelial growth factor in eye disease
2008 Standout
Involvement of mitophagy in oncogenic K-Ras-induced transformation
2011
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Components of the hepatocellular carcinoma microenvironment and their role in tumor progression
2017
Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis
2018 StandoutNobel
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Age-related macular degeneration
2018 Standout
Hepatic Stellate Cells in Liver Tumor
2020
Role of the gut microbiota in nutrition and health
2018 Standout
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
EMT: 2016
2016 Standout
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets
2010
Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix
2002
Does Hepatic Steatosis Affect Drug Metabolizing Enzymes in the Liver?
2011
Hepatic expression and cellular distribution of the glucose transporter family
2012
Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma
2014
Sorafenib induces autophagic cell death and apoptosis in hepatic stellate cell through the JNK and Akt signaling pathways
2015
The archaeal cell envelope
2011
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Type 2 diabetes mellitus
2015 Standout
Macrophage M1/M2 polarization
2020 Standout
A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth
1996
Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells
2018 Standout
Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice
2011
Role of TLR9 in hepatic stellate cells and experimental liver fibrosis
2008
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Microbial syntrophy: interaction for the common good
2013
NAFLD: A multisystem disease
2015 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Crystal structure of a bacterial homologue of glucose transporters GLUT1–4
2012 Nature
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Global gene expression of cells attached to a tissue engineering scaffold
2004 StandoutNobel
The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer
2016
Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
2013
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Direct observation of kinetic traps associated with structural transformations leading to multiple pathways of S-layer assembly
2012 StandoutNobel
Hepatic stellate cells secretes type I collagen to trigger epithelial mesenchymal transition of hepatoma cells.
2014
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Drusen proteome analysis: An approach to the etiology of age-related macular degeneration
2002
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
2017 Standout
Sorsby Fundus Dystrophy: Novel Mutations, Novel Phenotypic Characteristics, and Treatment Outcomes
2015
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases
2003 Standout
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle
2015 StandoutNobel
Altered copper homeostasis underlies sensitivity of hepatocellular carcinoma to copper chelation
2020
Works of Thomas Amann being referenced
Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma
2009
Reduced Expression of Fibroblast Growth Factor Receptor 2IIIb in Hepatocellular Carcinoma Induces a More Aggressive Growth
2010
Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells
2009
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma
2007
Targeting Melanoma Metastasis and Immunosuppression with a New Mode of Melanoma Inhibitory Activity (MIA) Protein Inhibition
2012
A novel Ser156Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy with unusual clinical features
1995
GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis
2009
Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis
2011
Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression
2009
GLUT1 as a therapeutic target in hepatocellular carcinoma
2009
Causal Modeling of Cancer-Stromal Communication Identifies PAPPA as a Novel Stroma-Secreted Factor Activating NFκB Signaling in Hepatocellular Carcinoma
2015
New Insights into the Lifestyle of the Cold-Loving SM1 Euryarchaeon: Natural Growth as a Monospecies Biofilm in the Subsurface
2006
A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy.
1996